In this white paper from Humana, the authors discuss how the aftermath of COVID-19 will require the frequent use of screeners and tools to assess changes in health status, including health-related quality of life and social health. Taking into account the results that matter most to patients will be key to improving health outcomes.
What will health care require after COVID-19, which exposed disjointed care delivery, health-related social factors, and misaligned incentives? In this white paper from Humana, Andrew Renda, MD, Elizabeth B. Walden, MA, and Christiana Ilesanmi discuss how the swift and sudden innovation forced by the pandemic won't be complete without real-time tracking of health indicators that include patient-reported data to improve health outcomes.
Click on the PDF below to download.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More